Evidence map›Paper›PMID 30048502›Full record

ArticlePloS one2018

Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.

Almiro Tivane, Rodney Daniels, Neuza Nguenha, Loira Machalele, Afonso Nacoto, Mirela Pale, Edirsse Mateonane, Sandra Mavale, Josina Chilundo, Délcio Muteto and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Almiro TivaneDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.ORCID 0000-0002-8308-4136
Rodney DanielsFrancis Crick Institute, Worldwide Influenza Centre, London, United Kingdom.
Neuza NguenhaDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Loira MachaleleDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Afonso NacotoDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Mirela PaleDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Edirsse MateonaneDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Sandra MavalePediatric Department, Maputo Central Hospital, Maputo, Mozambique.
Josina ChilundoPediatric Department, Maputo Central Hospital, Maputo, Mozambique.
Délcio MutetoDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Judite SalênciaDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Félix AlbatiDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Eduardo GudoDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
Tufária MussáDepartment of Technologic Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique.
John McCauleyFrancis Crick Institute, Worldwide Influenza Centre, London, United Kingdom.
Instituto Nacional de Saúde · MZMaputo Central Hospital · MZThe Francis Crick Institute · GBEduardo Mondlane University · MZ

Funding

Surveillance and Response to Avian and Pandemic Influenza by the NationalU51IP000825 · IP · INSTITUTO NACIONAL DE SAUDE · PI JANI, ILESH · 2013 to 2015
$900k
NCI CLINICAL INVESTIGATOR AWARD PROGRAMK08CA001030 · NCI · UNIVERSITY OF WASHINGTON · PI THOMPSON, JOHN A · 1985 to 1987
–
Cancer Research UK FC001030Medical Research Council FC001030NCIRD CDC HHS U51 IP000825Wellcome Trust FC001030
6 · The paper itself

Abstract

backgroundDue to the high rate of antigenic variation of influenza virus, seasonal characterization of the virus is crucial to assess and monitor the emergence of new pathogenic variants and hence formulate effective control measures. However, no study has yet been conducted in Mozambique to assess genetic, antigenic and antiviral susceptibility profile of influenza virus.

methodsA subset of samples (n = 20) from influenza positive children detected in two hospitals in Maputo city during 2015 season as part of the implementation of influenza surveillance system, were selected. The following assays were performed on these samples: antigenic characterization by hemagglutination inhibition assay, genetic characterization by Sanger sequencing of hemagglutinin (HA) and neuraminidase (NA) and susceptibility to oseltamivir and zanamivir (NA inhibitors) by enzymatic assay.

resultsThe A(H1N1)pdm09 subtype viruses remained closely related antigenically and genetically to the 2016 vaccine virus A/California/7/2009 and other widely distributed viruses belonging to genetic group 6B. The majority of influenza A(H3N2) viruses studied were antigenically similar to the 2016-2017 vaccine virus, A/Hong Kong/4801/2014, and their HA and NA gene sequences fell into genetic subclade 3C.2a being closely related to viruses circulating in southern Africa. The influenza B viruses were antigenically similar to the 2016 season vaccine virus and HA sequences of all three fell into the B/Yamagata-lineage, clade 3, but contained NA genes of the B/Victoria-lineage. All tested viruses were sensitive to oseltamivir and zanamivir.

conclusionOverall, all Mozambican influenza A and B viruses were most closely related to Southern African viruses and all were sensitive to oseltamivir and zanamivir. These findings suggest the existence of an ecological niche of influenza viruses within the region and hence highlighting the need for joint epidemiologic and virologic surveillance to monitor the evolution of influenza viruses.

Indexed as

AnimalsAntiviral AgentsChildChild, PreschoolDogsFemaleHemagglutination Inhibition TestsHemagglutinin Glycoproteins, Influenza VirusHumansInfantInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanMadin Darby Canine Kidney CellsAntiviral AgentsHemagglutinin Glycoproteins, Influenza VirusNeuraminidaseOseltamivirViral ProteinsZanamivir

Identifiers

PMID30048502
PMCPMC6062064
OpenAlexW2884922776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.